Lumos Pharma Probability of Future Stock Price Finishing Over 0.0
Lumos Pharma's future price is the expected price of Lumos Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Lumos Pharma performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Please specify Lumos Pharma's target price for which you would like Lumos Pharma odds to be computed.
Lumos |
Lumos Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lumos Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lumos Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lumos Pharma is not yet fully synchronised with the market data | |
| Lumos Pharma has some characteristics of a very speculative penny stock | |
| Lumos Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.05 M. Net Loss for the year was (34.03 M) with profit before overhead, payroll, taxes, and interest of 1.52 M. | |
| Lumos Pharma currently holds about 79.51 M in cash with (31.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.49. | |
| Roughly 33.0% of the company outstanding shares are owned by corporate insiders |
Lumos Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lumos Stock often depends not only on the future outlook of the current and potential Lumos Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lumos Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.1 M | |
| Cash And Short Term Investments | 36.1 M |
Lumos Pharma Technical Analysis
Lumos Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Lumos Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lumos Pharma. In general, you should focus on analyzing Lumos Stock price patterns and their correlations with different microeconomic environments and drivers.
Lumos Pharma Predictive Forecast Models
Lumos Pharma's time-series forecasting models is one of many Lumos Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lumos Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lumos Pharma
Checking the ongoing alerts about Lumos Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lumos Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lumos Pharma is not yet fully synchronised with the market data | |
| Lumos Pharma has some characteristics of a very speculative penny stock | |
| Lumos Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.05 M. Net Loss for the year was (34.03 M) with profit before overhead, payroll, taxes, and interest of 1.52 M. | |
| Lumos Pharma currently holds about 79.51 M in cash with (31.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.49. | |
| Roughly 33.0% of the company outstanding shares are owned by corporate insiders |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Lumos Stock
If you are still planning to invest in Lumos Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lumos Pharma's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |